Study to assess the use of Triamcinolone acetonide injection in suprachoroidal space of eye for treatment of non infectious uveitis (an inflammatory disease of eye)

Randomized clinical trial to assess the efficacy of Suprachoroidal Triamcinolone Acetate injection in Non-infectious Uveitis - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/082400

Enrollment

196

Registered

2025-03-17

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H201- Chronic iridocyclitis

Interventions

Intervention1: Suprachoroidal injection of Triamcinolone Acetonide by indigenously designed suprachoroidal needle (Patent no 444428): Procedure will be done in operation theater. Intervention eye will

Eligibility

Inclusion criteria

Inclusion criteria: Newly diagnosed patients of all types (Anterior, intermediate, posterior and pan) uveitis Patients who give informed consent for the study

Exclusion criteria

Exclusion criteria: uncontrolled glaucoma, uncontrolled diabetes, or any other active ocular disease or infection

Design outcomes

Primary

Measure	Time frame
Improvement in visual acuity Reduction in inflammationTimepoint: (0,1,3,15) day (1,3,6) month	—

Secondary

Measure	Time frame
Reduction in central macular thicknessTimepoint: 0 day, 1 month, 6 month	—

Countries

India

Contacts

Public ContactDr Lubna Khan

GSVM Medical College Kanpur

perwezkhan@gmail.com9451875355

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026